Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis From the National Cancer Data Base.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Oncology

• Publication date

  2016-10-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2016.66.7352PMID 27269944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation.

  2016cited by this paper
• Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience.

  2016cited by this paper
• Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial.

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• Sensitivity Analysis Without Assumptions

  2015cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

  2014cited by this paper
• Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

  2014cited by this paper
• Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study.

  2014cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.

  2013cited by this paper
• The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments

  2013cited by this paper
• Contrasting treatment‐specific survival using double‐robust estimators

  2012cited by this paper
• Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer.

  2012cited by this paper
• The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.

  2011cited by this paper
• Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

  2009cited by this paper
• Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.

  2009cited by this paper
• Palliative treatment of intractable hematuria in context of advanced bladder cancer: a systematic review.

  2009cited by this paper
• Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond

  2007cited by this paper
• Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis

  2006cited by this paper
• Palliative radiation therapy.

  2005cited by this paper
• Radical cystectomy in patients aged ≥ 75 years: an updated review of patients treated with curative and palliative intent

  2005cited by this paper
• Medical and surgical palliative care of patients with urological malignancies.

  2005cited by this paper
• Four years experience in bladder preserving management for muscle invasive bladder cancer.

  2005cited by this paper
• Adjusted survival curves with inverse probability weights

  2004cited by this paper
• Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

  2003cited by this paper
• Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer.

  2003cited by this paper
• Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.

  2002cited by this paper
• Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.

  2001cited by this paper
• Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial.

  2001cited by this paper
• Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer.

  2001cited by this paper
• Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.

  1999cited by this paper
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

  1992cited by this paper
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

  1992cited by this paper
• The distribution of secondary growths in cancer of the breast. 1889.

  1989cited by this paper
• Palliative radiation therapy.

  1985cited by this paper
• A review of goodness of fit statistics for use in the development of logistic regression models.

  1982influential reference
• THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.

  1889cited by this paper

• Oligometastatic Bladder Cancer: Current Definitions, Diagnostic Challenges, and Evolving Therapeutic Strategies

  2026cites this paper
• Radiation Therapy Improves Survival in Patients with Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Study

  2025cites this paper
• Role of radiotherapy in the management of bladder cancer: Recommendations of the French Society for Radiation Oncology, 2025 update.

  2025cites this paper
• European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.

  2025cites this paper
• Cystectomy in Metastatic Bladder Cancer: Feasibility, Safety and Outcomes.

  2025cites this paper
• Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024)

  2024cites this paper
• The Role of Radiotherapy to the Primary Site in Oropharyngeal Cancer with Limited Metastases—An Analysis of a Hospital-Based Registry

  2024cites this paper
• 2024 CUA-GUMOC Expert Report: Management of unresectable locally advanced and metastatic urothelial carcinoma.

  2024cites this paper
• The evolving treatment landscape of metastatic urothelial cancer

  2024cites this paper
• Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases.

  2024cites this paper
• Definitions, outcomes and perspectives for oligometastatic bladder cancer: towards a standardized terminology

  2024cites this paper
• Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study

  2024cites this paper
• Management of patients with muscle-invasive bladder cancer with clinical evidence of pelvic lymph node metastases

  2024cites this paper
• Radiotherapy in metastatic bladder cancer

  2024cites this paper
• Retrospective Analysis of a Cohort of Patients with Metastatic Bladder Cancer with Metastatic Sites Limited to the Pelvis and Retroperitoneum Treated at a Single Institution between 2009 and 2020

  2023cites this paper
• The role of radiation therapy for de novo metastatic bladder and renal cancers.

  2023cites this paper
• Re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J Clin Oncol. In press. https://doi.org/10.1200/jco

  2023cites this paper
• Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future

  2023influential citation
• Regional differences in metastatic urothelial carcinoma of the urinary bladder patients across the United States SEER registries.

  2023cites this paper
• The role of radiotherapy in metastatic bladder cancer

  2022cites this paper
• Cytoreductive Surgery in Patients with Urothelial Bladder Cancer.

  2022cites this paper
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Urothelial Origin: a Case Report and Literature Review

  2022cites this paper
• Survival Impact of Nephroureterectomy for De Novo Stage IV Nonmetastatic and Metastatic Upper Tract Urothelial Carcinoma

  2022cites this paper
• Efficacy of Surgery on the Primary Tumour in Patients with Metastatic Bladder Cancer: A Comprehensive Review

  2022cites this paper
• Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy.

  2022cites this paper
• Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients

  2022cites this paper
• Definitive Local Therapy Is Associated with Improved Survival in Metastatic Soft Tissue Sarcomas

  2021cites this paper
• Lokal fortgeschrittene oder oligometastasierte Blasenkarzinome – Stellenwert der Lokaltherapie von Primärtumor und Metastasen

  2021cites this paper
• Comparative effectiveness analysis of first-line immunotherapy versus chemotherapy in metastatic urothelial carcinoma of the bladder.

  2021cites this paper
• Utilization and outcomes of metastasectomy for patients with metastatic urothelial cancer: An analysis of the national cancer database.

  2021cites this paper
• High-intensity local treatment of clinical node-positive urothelial carcinoma of the bladder alongside systemic chemotherapy improves overall survival.

  2021influential citation
• Das Harnblasenkarzinom der Frau

  2021cites this paper
• Locoregional Treatment for De Novo Metastatic Nasopharyngeal Carcinoma

  2021cites this paper
• Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma.

  2021cites this paper
• Post-operative and survival outcomes after cytoreductive surgery in the treatment of metastatic upper tract urothelial carcinoma.

  2021cites this paper
• The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder

  2020cites this paper
• Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database.

  2020cites this paper
• The Role of Surgery in Initially Metastatic Urothelial Carcinoma: Informing a Definitive Trial.

  2020cites this paper
• Metastasectomy could not improve the survival of metastatic urothelial carcinoma: evidence from a meta-analysis

  2020cites this paper
• Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma.

  2020cites this paper
• Efficacy and Safety of Locoregional Radiotherapy With Chemotherapy vs Chemotherapy Alone in De Novo Metastatic Nasopharyngeal Carcinoma: A Multicenter Phase 3 Randomized Clinical Trial.

  2020cites this paper
• Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer?

  2020cites this paper
• The essence of real-world study in cancer research

  2020cites this paper
• Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis

  2020cites this paper
• Brachytherapy-based radiotherapy is associated with improved survival for newly diagnosed metastatic cervical cancer.

  2020cites this paper
• The impact of gender on oncologic outcomes of bladder cancer

  2019cites this paper
• Contemporary Survival Rates for Muscle-Invasive Bladder Cancer Treated With Definitive or Non-Definitive Therapy.

  2019cites this paper
• Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.

  2019cites this paper
• Real-world data: towards achieving the achievable in cancer care

  2019cites this paper
• The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder

  2019cites this paper
• Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race‐based differences in survival?

  2019cites this paper
• More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder

  2019cites this paper
• Is the extirpative surgery for primary tumor helpful for the patients with metastatic urothelial cancer at the time of diagnosis?

  2019influential citation
• The role of metastatic burden in cytoreductive/consolidative radical cystectomy

  2019cites this paper
• Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy.

  2018cites this paper
• Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy

  2018cites this paper
• To resect or not to resect: The hamletic dilemma of primary tumor resection in patients with asymptomatic stage IV colorectal cancer.

  2018cites this paper
• [ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].

  2018cites this paper
• Metastasectomy in older adults with urothelial carcinoma: Population-based analysis of use and outcomes.

  2018cites this paper
• Palliative Chirurgie beim metastasierten Urothelkarzinom

  2018influential citation
• Definitive local therapy is associated with improved overall survival in metastatic cervical cancer.

  2018cites this paper
• Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma

  2018cites this paper
• Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review

  2018cites this paper
• Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis.

  2018cites this paper
• Retroperitoneal vs Transperitoneal Robot-assisted Partial Nephrectomy: Comparison in a Multi-institutional Setting.

  2018cites this paper
• Impact of Radical Prostatectomy on Long‐Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration

  2017cites this paper
• The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy.

  2017cites this paper
• Taking it to the HILT: High-intensity local treatment with radical cystectomy for metastatic bladder cancer.

  2017cites this paper
• The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review.

  2017cites this paper
• Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder

  2017cites this paper
• BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment?

  2017cites this paper
• Radical cystectomy in patients with disseminated disease: An assessment of perioperative outcomes using the National Surgical Quality Improvement Program database.

  2017cites this paper
• Radical Treatment of the Primary Tumor in Metastatic Bladder Cancer: Potentially Dangerous Findings From Observational Data.

  2017influential citation
• Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base

  2017cites this paper
• Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.

  2017cites this paper
• Secondary data sources for health services research in urologic oncology.

  2017cites this paper
• Wann ist bei eingetretener Metastasierung des Harnblasenkarzinoms die operative Entfernung des Primärtumors angezeigt und gibt es eine wissenschaftliche Grundlage dafür?

  2017cites this paper
• Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer

  2017cites this paper
• Comparative effectiveness research methodology using secondary data: A starting user's guide.

  2017cites this paper
• Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why?

  2016cites this paper
• Impact of Baseline Characteristics on the Survival Benefit of High-Intensity Local Treatment in Metastatic Urothelial Carcinoma of the Bladder.

  2016cites this paper
• Building bridges in urothelial carcinoma to face common challenges

  2016cites this paper